Vanessa K. Pazdernik, MS
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota
Original Research
Long-Term Outcomes of IV Ketamine and IN Esketamine in Treatment-Refractory Depression
July 30, 2025
The study results suggest that patients with treatment-resistant depression who are on maintenance treatment require less frequent treatments with IV ketamine compared to IN esketamine.
